明尼苏达州强制普遍筛查先天性巨细胞病毒的影响
该回顾性队列研究分析了132例18岁以下cCMV患者,比较了筛查指南实施前(2021年及以前)、推荐但未强制(2022年)和普遍筛查(2023年及以后)三个队列。结果显示普遍筛查后首次听力学会诊年龄显著降低,轻度听力损失诊断数量增加,接受感染科和耳鼻喉科会诊及抗病毒治疗的患者数量增加。
要点
- 普遍筛查使cCMV诊断后首次听力学会诊年龄显著降低。
- 普遍筛查后轻度听力损失诊断数量增加,但重度至极重度听力损失无差异。
- 普遍筛查后感染科和耳鼻喉科会诊及抗病毒治疗数量增加。
核心结论
- 普遍cCMV筛查降低了诊断后首次听力学会诊的年龄,增加了轻度听力损失的诊断数量,并增加了cCMV相关检查评估的患者数量。
研究设计与样本
- 回顾性队列研究,纳入某三级学术医院2021年1月至2024年2月诊断的132例18岁以下cCMV患者,分为三个队列:2021年及以前(筛查指南前)、2022年(推荐但未强制筛查)、2023年及以后(普遍筛查)。
临床怎么用
- 普遍cCMV筛查可促使更早进行听力学评估,并提高轻度听力损失的检出率。
- 筛查实施后应关注感染科和耳鼻喉科会诊及抗病毒治疗需求的增加。
局限性
- 需要进一步研究评估普遍筛查的长期听力学结局和获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate trends in evaluation and management of patients with cCMV at a major pediatric center following the institution of universal cCMV screening. STUDY DESIGN: Retrospective cohort study. SETTING: Tertiary academic hospital. METHODS: Patients <18 years with a diagnosis of cCMV between January 2021 and February 2024 were examined. Three cohorts were analyzed: 2021 and earlier (before screening guidelines), 2022 (screening recommended but not mandated), and 2023 and later (universal screening). Patient charts were reviewed for workup and treatment of cCMV. RESULTS: 132 patients met criteria. There was a significant difference in age at first audiology visit following cCMV diagnosis between cohorts 1 (0.71 ± 1.8), 2 (0.26 ± 0.23), and 3 (0.07 ± 0.06) (P = .02). There was a significant increase in the absolute number of mild hearing loss diagnoses in 2023 and later compared to 2022 (8 and 2, P < .01), but no difference in severe to profound hearing loss diagnoses between the cohorts (5 and 3, P = .2). Between cohorts 2 and 3, there were increases in the absolute number of patients undergoing ID consultation (11 vs 24), ENT consultation (9 vs 22), and treatment with antiviral therapy (7 vs 9) (P < .01). CONCLUSIONS: Universal cCMV screening decreased the age at first audiology visit following cCMV diagnosis. Universal screening increased the number of diagnoses of mild hearing loss. The number of patients undergoing workup for cCMV also increased. Additional research is needed to assess the long-term audiologic outcomes and benefits of universal screening.
引用
- Holden L, Carlson AM, Jayawardena A, et al. The Impact of Mandated Universal Screening for Congenital Cytomegalovirus: The Minnesota Experience. Otolaryngol Head Neck Surg. 2026. PMID: 41649243. doi:10.1002/ohn.70158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。